1-2 of 2
David Fabrizio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A41: Analytic validation and clinical feasibility of a next-generation sequencing assay to assess tumor mutational burden from blood (bTMB) as a biomarker for anti-PD-L1 response in NSCLC

Free
Daniel S. Lieber, Emily White, Jacob Silterra, Shan Zhong, Tina Brennan, Michael Coyne, Mark Kennedy, David R. Gandara, Marcin Kowanetz, Sarah M. Paul, Erica Schleifman, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Lukas Amler, Todd Riehl, Craig Cummings, Priti S. Hegde, Wei Zou, Alan Sandler, Marcus Ballinger, Tony Mok, David S. Shames, Doron Lipson, Christine Malboeuf, David Fabrizio
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): A41.
https://doi.org/10.1158/2326-6074.TUMIMM17-A41
Published: 01 September 2018
View articletitled, Abstract A41: Analytic validation and clinical feasibility of a next-generation sequencing assay to assess tumor mutational burden from blood (bTMB) as a biomarker for anti-PD-L1 response in NSCLC
Journal Articles

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Free
Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Erik Yusko, Yaomin Xu, Xingyi Guo, Riley C. Ennis, David Fabrizio, Zachary R. Chalmers, Joel Greenbowe, Siraj M. Ali, Sohail Balasubramanian, James X. Sun, Yuting He, Dennie T. Frederick, Igor Puzanov, Justin M. Balko, Justin M. Cates, Jeffrey S. Ross, Catherine Sanders, Harlan Robins, Yu Shyr, Vincent A. Miller, Philip J. Stephens, Ryan J. Sullivan, Jeffrey A. Sosman, Christine M. Lovly
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11): 959–967.
https://doi.org/10.1158/2326-6066.CIR-16-0143
Published: 31 October 2016
View articletitled, Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Open the PDF for Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade in another window
Includes: Supplementary data